Maximising Cancer Prevention and Early Detection in the Australian Cancer Plan: Where Are We Now and What Should Come Next?
6 affiliations
- 1Flinders Health and Medical Research Institute, College of Medicine and Public Health Flinders University Adelaide South Australia Australia
- 2Gastroenterology Department, Flinders Medical Centre Southern Adelaide Local Health Network Adelaide South Australia Australia
- 3National Centre for Education and Training on Addiction, Flinders Health and Medical Research Institute, College of Medicine and Public Health Flinders University Adelaide South Australia Australia
- 4Melbourne School of Population and Global Health University of Melbourne Melbourne Victoria Australia
- 5Department of General Practice and Primary Care and Collaborative Centre for Cancer Genomic Medicine University of Melbourne Melbourne Victoria Australia
- 6Flinders LiveWell Cancer Research Centre, Caring Futures Institute, College of Health and Enablement Flinders University Adelaide South Australia Australia
Abstract
Cancer accounts for three in 10 deaths in Australia, yet many cases are preventable or can be detected at an early stage. Maximising cancer prevention and early detection is one of the six strategic objectives of the 10‐year Australian Cancer Plan. This perspective article reviews the current progress and challenges of reducing the cancer burden, along with future opportunities. It explores how to address modifiable risk factors, particularly tobacco smoking, alcohol use and sun exposure and the advances in screening programs for bowel, breast, cervical and lung cancers. It highlights the potential for risk‐stratified and genomics‐informed screening, emphasising the need to support participation through equitable and culturally safe approaches.
Related
- Parental attitudes toward myopia prevention: insights from an Australian survey
- Should all cystectomies be centralised?-a retrospective study of perioperative and pathological outcomes of radical cystectomy in a regional Australian centre.
- Temporal Trends in Six Major Cancers: Implications for Lifestyle-Based Cancer Prevention and Early Detection Across the Life Course.
- From HPV Detection to Cancer Prevention: The Role of Infection Persistence, Genotype, and Anatomical Site in HPV-Associated Cancers
- Knowledge, attitudes and practices among Australian community pharmacists towards naloxone and overdose prevention: a national cross-sectional study
BibTeX
@article{symonds2026maximising,
title = {{Maximising Cancer Prevention and Early Detection in the Australian Cancer Plan: Where Are We Now and What Should Come Next?}},
author = {Erin L. Symonds and Billie Bonevski and Richard Edwards and Nathan J. Harrison and Sana Ishaque and Nicole M. Rankin and Sibel Saya and Renee J. Smith and Carolyn Ee},
journal = {The Medical journal of Australia},
year = {2026},
month = oct,
doi = {10.5694/mja2.70323},
url = {https://europepmc.org/article/PMC/PMC13722942},
note = {CC BY},
}
RIS
TY - JOUR
TI - Maximising Cancer Prevention and Early Detection in the Australian Cancer Plan: Where Are We Now and What Should Come Next?
AU - Erin L. Symonds
AU - Billie Bonevski
AU - Richard Edwards
AU - Nathan J. Harrison
AU - Sana Ishaque
AU - Nicole M. Rankin
AU - Sibel Saya
AU - Renee J. Smith
AU - Carolyn Ee
PY - 2026
DA - 2026/10/31
JO - The Medical journal of Australia
DO - 10.5694/mja2.70323
UR - https://europepmc.org/article/PMC/PMC13722942
AB - Cancer accounts for three in 10 deaths in Australia, yet many cases are preventable or can be detected at an early stage. Maximising cancer prevention and early detection is one of the six strategic objectives of the 10‐year Australian Cancer Plan. This perspective article reviews the current progress and challenges of reducing the cancer burden, along with future opportunities. It explores how to address modifiable risk factors, particularly tobacco smoking, alcohol use and sun exposure and the advances in screening programs for bowel, breast, cervical and lung cancers. It highlights the potential for risk‐stratified and genomics‐informed screening, emphasising the need to support participation through equitable and culturally safe approaches.
SN - 0025-729X
SN - 1326-5377
ER -